Subsequently, a co-immunoprecipitation (co-IP) assay was performed to determine if there was a direct protein-protein interaction between E2F4 and DSCC1, which could regulate abnormal DSCC1 expression in GC. This evidence concerns the gene E2F4 and gastric cancer.